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Abstract: A hypoglycemia-induced fall is common in older persons with diabetes. The etiology 
of falls in this population is usually multifactorial, and includes microvascular and macrovas-
cular complications and age-related comorbidities, with hypoglycemia being one of the major 
precipitating causes. In this review, we systematically searched the literature that was available up 
to March 31, 2014 from MEDLINE/PubMed, Embase, and Google Scholar using the following 
terms: hypoglycemia; insulin; diabetic complications; and falls in elderly. Hypoglycemia, defined 
as blood glucose ,4.0 mmol/L (70 mg/dL) requiring external assistance, occurs in one-third of 
elderly diabetics on glucose-lowering therapies. It represents a major barrier to the treatment 
of diabetes, particularly in the elderly population. Patients who experience hypoglycemia are 
at a high risk for adverse outcomes, including falls leading to bone fracture, seizures, cogni-
tive dysfunction, and prolonged hospital stays. An increase in mortality has been observed in 
patients who experience any one of these events. Paradoxically, rational insulin therapy, dosed 
according to a patient’s clinical status and the results of home blood glucose monitoring, so 
as to achieve and maintain recommended glycemic goals, can be an effective method for the 
prevention of hypoglycemia and falls in the elderly. Contingencies, such as clinician-directed 
hypoglycemia treatment protocols that guide the immediate treatment of hypoglycemia, help 
to limit both the duration and severity of the event. Older diabetic patients with or without 
underlying renal insufficiency or other severe illnesses represent groups that are at high risk 
for hypoglycemia-induced falls and, therefore, require lower insulin dosages. In this review, 
the risk factors of falls associated with hypoglycemia in elderly diabetics were highlighted and 
management plans were suggested. A target hemoglobin A1c level between 7% and 8% seems 
to be more appropriate for this population. In addition, the first-choice drugs should have good 
safety profiles and have the lowest probability of causing hypoglycemia – such as metformin 
(in the absence of significant renal impairment) and incretin enhancers – while other therapies 
that may cause more frequent hypoglycemia should be avoided.
Keywords: hypoglycemia, diabetes complications, falls, fractures, elderly
Introduction
Diabetes is one of the most common chronic conditions in older adults.1 The number 
of elderly individuals with diabetes is also growing worldwide because of increased 
life expectancy and the incidence of the disease in the general population.1,2 In 2013, 
it was estimated that 382 million people globally had diabetes, and this number is 
predicted to increase to 592 million by 2035.3 The burden of diabetes in the elderly is 
felt most in industrially advanced countries.4 For instance, of the 3.2 million people in 
the UK with diabetes, at least half are over 65 years old.4 The prevalence of diabetes in 
the elderly is more than 10% when compared with 6% in the general adult  population, 
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and it approaches 25% in nursing home residents.4,5 The 
management of elderly patients presents unique challenges. 
Episodes of hypoglycemia are a major complication of 
the treatment of diabetes with insulin and some other oral 
medications.6,7 The consequences of hypoglycemia may be 
much greater in the frail older population than in younger 
adults.6 For instance, falls may be the first presentation of 
a hypoglycemic symptom in the elderly, with devastating 
consequences including bone fracture, deteriorating quality 
of life, and death.6,7 Apart from the high rate of falls in this 
group, the prevalence of osteoporosis is also high, largely 
due to coexisting diseases including diabetes, which are 
associated with poor bone health.8 Furthermore, multiple 
medications have been implicated in causing osteoporosis in 
the older diabetic population.8 The aim of this review was to 
highlight the risk factors of hypoglycemia-induced falls in 
the diabetic elderly population and to recommend preven-
tive measures aimed at minimizing the event. MEDLINE/
PubMed (US National Library of Medicine, Bethesda, MD, 
USA), Embase (Elsevier BV, Amsterdam, the Netherlands), 
and Google Scholar (Google, Mountain View, CA, USA) 
were searched on March 31, 2014 using combinations of 
the following search terms: hypoglycemia; insulin; diabetic 
complications and falls in elderly.
Prevalence and symptoms  
of hypoglycemia in the elderly
The true prevalence of hypoglycemia in the elderly is 
unknown, largely due to variations in its definition.7 Most 
studies defined hypoglycemia by relying on the recall of 
hypoglycemic events by participants.9,10 The accurate recall of 
hypoglycemia is notably difficult in any age group, and more 
so in the elderly population.11 For epidemiological purposes, 
severe hypoglycemia is usually defined as low blood glucose 
levels requiring external assistance for treatment.7 This is 
easier to measure, as it is usually more dramatic and offers 
good precision in terms of recall for up to 1 year in both types 
of diabetes.9,10 The frequency of severe hypoglycemia can also 
be corroborated with documentary evidence from medical 
emergency services.11 Thus, knowledge of the symptoms of 
hypoglycemia in the elderly is often poor.11,12 On the other 
hand, mild episodes of hypoglycemia are under-recognized by 
patients, relatives or carers, and their health care  providers.12 
Studies have shown a poor correlation between the recall 
of hypoglycemia by relatives and patients,13 with relatives 
tending to recall more episodes than patients. Furthermore, 
the recognition of mild hypoglycemia is made more difficult 
as the hypoglycemia symptom profile changes with age, as 
do the glycemic thresholds for symptom generation and 
cognitive impairment.14 Even if hypoglycemia is recognized, 
patients are known to under-report this to their doctors.15 
The annual prevalence of insulin-induced hypoglycemia in 
type 2 diabetic patients was reported to be high, accounting 
for up to 25% of cases, as compared to 7% of cases that were 
caused by sulphonylurea.6 In support of this, fewer cases 
of hypoglycemia caused by oral antidiabetic agents were 
observed. For instance, in a retrospective assessment in the 
elderly population, Bramlage et al16 noted that only 1% of 
reported episodes of symptomatic hypoglycemia was induced 
by oral antidiabetic agents.
The symptoms of hypoglycemia derive from a physiologi-
cal response to the change in glucose.17 Although symptoms 
may differ between people, in younger adults, these are 
usually easy to perceive.18 Hypoglycemia scores were devel-
oped from analyzing the most common symptoms that were 
reported by people experiencing hypoglycemia,18,19 and they 
comprise autonomic symptoms such as sweating, pounding 
heart, and neuroglycopenic symptoms in the form of confu-
sion and lightheadedness, and nonspecific symptoms such as 
malaise. In older people, the symptoms of hypoglycemia may 
be missed due to the coexistence of other nonspecific aged-
related ailments,20,21 and there is an overall reduced subjective 
awareness of hypoglycemia with increasing age.22 In younger 
people, autonomic symptoms of hypoglycemia tend to be 
more prominent than neuroglycopenic symptoms, although 
the latter also occur.22 These autonomic symptoms of hypo-
glycemia become less prominent with the increasing duration 
of diabetes, and also in older patients with diabetes.21,23 It has 
been postulated that this change in symptoms may be related 
to a reduced end-organ response in older people.21
Hypoglycemia-induced falls  
in the elderly
Falls among the elderly is one of the most frequent causes of 
unintentional injuries, causing close to 90% of hip and wrist 
fractures24,25 and 60% of head injuries.26 The  complications 
arising from long-term diabetes – namely, diabetic 
 neuropathy, retinopathy, and foot ulcer – are known to cause 
falls in elderly patients.27 A range of risk factors has been 
shown to cause falls in diabetic patients. These include age, 
a lack of balance, insulin therapy, a history of heart disease, 
osteoarthritis, peripheral neuropathy, a higher body mass 
index, and poor lower extremity performance.28–30 In general, 
elderly diabetic patients have been found to be at an increased 
risk of falls and disability.31,32 Hypoglycemia, one of the most 
feared acute complications of diabetes treatment, has been 
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shown to increase the risk of falls.32 The symptoms that lead to 
falls in hypoglycemic patients include trembling, shakiness, 
a decrease in cognitive ability, and palpitations.33,34
A fall during hypoglycemia can cause soft tissue damage, 
bone fractures, and head injuries, which may further cause 
delirium leading to recurrent falls.35 Frail elderly people, 
many of whom have other comorbidities such as osteoporosis, 
may be particularly vulnerable to bone fractures following 
a fall.24 The pain and disability that such trauma imposes 
on the affected individual and his or her relatives or  carers, 
and the enormous economic burden placed on health care 
resources, have recently been investigated, showing substan-
tial insurance claims in the elderly population.33 The risk of 
accidents resulting in hospital visits among people with type 
2 diabetes on medications (excluding insulin) was assessed 
retrospectively in a large United States health insurance 
database.33 Hypoglycemia was associated with significantly 
increased hazards for any accident (hazard ratio [HR]: 
1.39; 95% confidence interval [CI]: 1.21–1.59; P,0.001), 
accidental falls (HR: 1.36; 95% CI: 1.13–1.65; P,0.001), 
and motor vehicle accidents (HR: 1.82; 95% CI: 1.18–2.80; 
P,0.01).36 Similarly, a large retrospective observational 
study of more than 360,000 patients with type 2 diabetes 
aged over 65 years found 4.7% of those who had a docu-
mented hypoglycemic episode over the course of 1 year had 
a 70% higher chance of having a fall-related fracture (odds 
ratio: 1.7; 95% CI: 1.58–1.83); the odds still remained high 
even after correcting for potential confounders, such as the 
presence of diabetic peripheral neuropathy.33 In support of 
this, retrospective and case control studies have also sug-
gested increased hypoglycemia-related falls and fractures 
particularly in people with strict glycemic control who were 
on insulin therapy, but not among those on oral antidiabetes 
agents.10–12 Thus, in subjects with type 2 diabetes receiving 
insulin, hypoglycemia was associated with a significantly 
higher risk of accidents resulting in hospital visits, including 
accidents related to driving and falls.35
Hypoglycemia has a major adverse impact on quality of 
life among the elderly population.33,34 It is well known in clini-
cal practice that patients fear hypoglycemia more than any 
other diabetic complications.37 In the aged, hypoglycemia has 
been linked to poor outcomes – not only to falls and fractures, 
but also to an increased risk of accidents, hospitalizations, 
in-hospital mortality, frailty, and the long-term impairment 
of cognition including a risk of dementia.32,34–38 It is also 
associated with electrophysiological changes in the form of 
a prolonged QT interval – a known precipitant of cardiac 
dysrhythmia, and which may lead to falls in the elderly.39
Insulin and glycemic control  
leading to falls
Kennedy et al40 identified that insulin-treated diabetic patients 
were more likely to experience falls during a hypoglycemic 
episode. The study also identified that patients treated with 
insulin were more likely to sustain a fracture during the fall. 
The rate of accidents in insulin-treated patients was signifi-
cantly higher when compared to noninsulin-treated subjects. 
The profile of the insulin-treated patients was observed to be 
as follows: more women than men; an older age group; and 
with those with an increased length of hospitalization. The 
nature of the fracture was predominantly at the peripheral 
sites. Women were also more likely to develop fractures as 
a result of falls when compared with men.41 The number of 
recurrent falls was found to be much higher among diabetic 
patients. The factors that attributed to an increased risk of falls 
included the number of medications taken, increased levels of 
pain, a lack of physical activity, grip strength, and cognitive 
impairment.42 The role of glycemic control as a risk factor for 
falls has been controversial. Miller et al43 reported no relation 
between glycemic control and the risk of falls. Examining the 
risk factors for falls in diabetic patients,  Tilling et al44 reported 
that poorly controlled diabetic subjects were more prone to 
falls. Falls in elderly diabetics with or without hypoglycemia 
are common, accounting for up to 31% of reported episodes 
per year.7,45 Interestingly, hemoglobin A
1c
 (HbA
1c
) levels 
did not affect the risk of falls in patients not using insulin. 
 However, patients with HbA
1c
 ,6% and those using insulin 
were found to be at a higher risk of falls.45 Regulating HbA
1c
 
levels is of paramount importance in managing diabetes. 
While the regulation of HbA
1c
 is achieved by health practitio-
ners, it may also help in delaying the long-term complications 
associated with diabetes, and thereby falls as well.45
Diabetic microvascular 
complications leading to falls
Peripheral neuropathy has been recognized as one of the 
risk factors for falls. DeMott et al46 reported a significant 
association between falls and peripheral neuropathy. Diabetic 
subjects with peripheral neuropathy have been shown to have 
postural instability leading to falls.47 Dukas et al48 identified 
low creatinine clearance as an independent risk factor for 
falls. In their study examining the risk factors  contributing 
to falls in a diabetic cohort, Schwartz et al28 identified 
microvascular complications as one of the risk factors. The 
study found that reduced peripheral nerve function, vision 
impairment, and poor renal function attributed to falls in 
diabetic patients.28
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When investigating urge incontinence in elderly women, 
Brown et al49 found that falls and fractures occurred inde-
pendent of urge incontinence. The authors suggested that 
the early diagnosis and treatment of incontinence could help 
decrease falls in elderly people. Older individuals are often 
known to have difficulties in managing urinary frequency, as 
they rush to the bathroom to avoid urge incontinence, making 
them potentially vulnerable to falls.49
Oral antidiabetic medications  
contributing to falls and fracture
Medication is one of the risk factors associated with falls.42 
It has been established that the use of multiple prescribed 
medications in general increases the risk of falls in elderly 
people.50 When studied specifically in a diabetic population, 
Huang et al51 found that diabetic patients taking more than four 
medications were at a higher risk of falls. With an increase in 
medications, the associated risk of falling increased as well. 
Diabetic subjects on insulin are at higher risk of hypoglyce-
mia and falls than those on oral agents.7,35 Of those on oral 
antidiabetic medications, the risk of hypoglycemia is higher 
among subjects on sulphonylurea than those on other oral 
agents.16 On the other hand, the use of oral insulin sensitizers 
was not associated with falls.52 For example thiazolidinedione 
(TZD) and metformin have not been shown to increase the 
risk of falls.52,53 However, TZD was reported to increase the 
risk of fractures in diabetic patients by lowering bone forma-
tion and accelerated bone loss.54 No risk has been attributed 
to falls when patients used glucagon-like peptide-1 analogs 
or dipeptidyl peptidase-4 inhibitors.55 A range of risk factors 
contributing to falls is shown in Table 1.
Mechanism of falls due to diabetes
Falls in elderly diabetic subjects may be due to multiple 
factors. Apart from hypoglycemia, other well recognized 
complications of long-standing diabetes mellitus including 
peripheral neuropathy, impaired vision due to diabetic retino-
pathy or cataracts, autonomic neuropathy, and diabetic foot 
ulcers can each contribute meaningfully to fall risk through 
multiple mechanisms.27 The blurring of vision from hyper-
glycemia or hypoglycemia with an attendant osmotic effect 
on the lenses has also been linked to falls in diabetic elderly 
subjects.56,57 The global assessment of visual impairment has 
demonstrated a trend towards greater visual impairment in 
diabetics as compared with nondiabetics, albeit this is not 
significant and thus may signify the importance of determin-
ing other risk factors contributing to falls in subjects prone to 
hypoglycemia.56 Numerous studies suggested the possible link 
between falls and diabetes among the community-dwelling 
elderly population,31,38,58 with a significant risk being linked 
to proprioceptive deficits, impaired work performance, and 
strength of patients’ leg muscles.38,59,60 Furthermore, ortho-
static hypotension due to underlying autonomic neuropathy 
in elderly diabetic subjects has been linked to increased risk 
of falls.61,62 However, the contribution of orthostatic hypoten-
sion in causing falls in this group of the population has been 
questioned by others.63 Therefore, it is unlikely that the higher 
fall rate that was observed in diabetics was attributable to dif-
ferences in orthostatic changes in blood pressure alone. The 
lack of an observed significant difference in the prevalence 
of orthostatic hypotension or visual impairment suggests 
that other factors, perhaps related to peripheral neuropathies 
or diabetic foot complications, play a greater causal role.31 
Further studies confirming these findings in larger datasets 
while evaluating for the putative mechanism in relation to 
hypoglycemic episodes would be required.
Diabetes and fracture risk
Diabetes has been linked to an increased risk of osteoporosis.64 
Although type 1 diabetes has been shown to be  associated 
with lower bone mass, both types of diabetes have lower 
bone quality, even though patients with type 2 diabetes 
have higher bone mineral density values.65 Thus, those in 
the elderly diabetic population have a higher risk of frac-
tures than do their non-diabetic counterparts. Furthermore, 
low serum testosterone levels have been reported to be 
common in the elderly diabetic male population, with a 
high prevalence of osteoporosis.66 Apart from diabetes 
predisposing an individual to poor bone health, antidiabetic 
agents such as metformin have been reported to cause B12 
malabsorption, leading to neuropathy and a risk of falls in 
Table 1 Risk factors contributing to hypoglycemia-induced falls 
in elderly subjects with diabetes
Aspect studied Risk compared with  
controls (95% CI)
P-value
Diabetes42 HR: 1.63 (1.06–2.52) 0.017
Poorly controlled DM44 RR: 7.86 (2.94–20.79) ,0.05
insulin40 RR: 1.97 (1.68–2.32) ,0.001
insulin28 OR: 1.68 (1.37–2.07) ,0.05
insulin and HbA1c ,6%
45 OR: 4.36 (1.32–14.46) ,0.05
Renal impairment48 OR: 3.68 (1.38–9.82) 0.009
Medications list51 1.  4–5 medications;  
HR: 1.22 (1.04–1.43)
2.  6–7 medications;  
HR: 1.33 (1.12–1.58)
3.  .7 medications;  
HR: 1.79 (1.34–1.89)
– 
,0.01 
 
,0.01
Foot ulcers41 insensate feet; OR: 1.87  
(1.1–3.2)
,0.01
Abbreviations: CI, confidence interval; HR, hazard ratio; DM, diabetes mellitus; 
RR, relative risk; OR, odds ratio; HbA1c, hemoglobin A1c.
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elderly  diabetics.67 To date, no randomized controlled  trials 
have confirmed an association between metformin and vita-
min B12 malabsorption. Recently, the TZD group of oral 
antidiabetic agents has been linked to osteoporotic fractures 
in women, though age stratification has not been studied.68 
It has been suggested that TZD may cause bone loss and 
further increase fracture risk, placing it in the category of 
drugs that cause secondary osteoporosis.69 The mechanism of 
TZD-induced bone loss includes  unbalanced bone remodel-
ing processes resulting from decreased bone formation and 
increased bone resorption.69 Risk factors for the development 
of TZD-induced secondary osteoporosis are advanced age, 
female sex, and duration of treatment.68,69 Human and animal 
studies suggest that aging and estrogen deficiency confound 
TZD-induced bone loss and this combination (ie, aging and 
estrogen deficiency) may play a significant role in the patho-
genesis of secondary osteoporosis.68,69
Prevention of hypoglycemia-induced 
falls in elderly diabetic patients
A holistic approach is necessary to prevent hypoglycemia-
induced falls in the elderly diabetic subject.70,71 This is 
achieved by evaluating and addressing the risk factors 
that lead to falls, so as to ensure that preventive measures 
outweigh risk factors (Figure 1). Individualizing targets for 
diabetic control has been recommended particularly in the 
elderly, so as to minimize hypoglycemia while maintain-
ing  reasonable blood glucose control.70 In the elderly, an 
HbA
1c
 target of ,7.5% or even 8% has been advised by the 
American Diabetes Association and the European Associa-
tion for the Study of Diabetes.71 Antidiabetic medications 
noted more likely to cause hypoglycemia, such as insulin/
sulphonylurea have been suggested to be used as second line 
agents in elderly diabetic subjects.70 To this end, the use of 
incretin-based therapy and metformin, which have a minimal 
risk of hypoglycemia, is plausible.71 Furthermore, improving 
gait and balance in older diabetic patients could help prevent 
or lessen the frequency of falls.72 Improving resistance and 
balance training has also been shown to reduce the risk of 
falls in this group.73 Fall prevention programs designed for the 
elderly have been shown to improve this group’s functional 
performance.74 The range of exercises suggested includes 
exercising for 3 days a week.75
The choice of antidiabetic medications that are less 
likely to affect bone health, particularly in the elderly 
that are at risk of osteoporosis, is prudent. The enhanced 
bone-resorption property of TZD may be reduced by using 
combination therapy with other antidiabetic therapies.52 In 
addition, bone loss may be prevented by using the available 
antiosteoporotic drugs, or by the development of a new 
class of selective TZDs, which may have sparing or even 
beneficial effects on the bones.69 In addition, risk factors 
for falls such as advanced age, impaired balance, cardio-
vascular disease, and neuro pathy should be evaluated, so 
as to implement a program that combines regular exercise, 
vitamin D supplementation, the withdrawal of psychotro-
pic medications, a visual assessment, an environmental 
hazard assessment and modification, and the use of hip 
protectors.72
Conclusion
In summary, hypoglycemia-induced falls are common in 
elderly diabetic individuals who are at risk of fractures 
and adverse outcomes, including the loss of independence 
and death.31 Many hypoglycemia events can be prevented 
by using appropriately dosed insulin, which is adjusted 
based on daily home blood glucose monitors in subjects 
on insulin therapy.6 Avoiding the use of sulfonylureas in 
patients aged .65 years, in those with renal insufficiency, 
or in those who are receiving basal insulin preparations, can 
reduce the risk of hypoglycemia.70,71 Due to increased risk 
of hypoglycemia and its complications in this group of the 
population, maintenance of tight glycemic control should 
be discouraged.71 Other associated risk factors for falls in 
the elderly should be looked for and addressed accordingly. 
Oral antidiabetic agents that are least likely to cause hypo-
glycemia should be the first choice of therapy in this group. 
Risk factors
Diabetes
Insulin
Other medications Minimize medication
list
HbA1c 7%–8%
Environmentalhazard management
Avoid insulin or
sulphonylurea
Prevention
Figure 1 Key factors in preventing hypoglycemia-induced falls in the elderly.
Abbreviation: HbA1c, hemoglobin A1c.
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Metformin and/or dipeptidyl peptidase inhibitors should be 
used unless contraindicated.
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